Latest Breaking News On - Cellectar biosciences daily - Page 1 : comparemela.com

Cellectar Biosciences (CLRB) to Release Earnings on Tuesday

Cellectar Biosciences (CLRB) to Release Earnings on Tuesday
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Roth mkmCellectar biosciencesCellectar biosciences company profileCellectar biosciences incGet free reportCellectar biosciences daily

Cellectar Biosciences (CLRB) Set to Announce Earnings on Tuesday

Cellectar Biosciences (CLRB) Set to Announce Earnings on Tuesday
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Cellectar biosciencesRoth mkmCellectar biosciences incCellectar biosciences company profileGet free reportCellectar biosciences daily

Roth Mkm Boosts Cellectar Biosciences (NASDAQ:CLRB) Price Target to $28 00

Cellectar Biosciences (NASDAQ:CLRB – Free Report) had its price target lifted by Roth Mkm from $20.00 to $28.00 in a research note published on Thursday morning, Benzinga reports. The brokerage currently has a buy rating on the biopharmaceutical company’s stock. CLRB has been the subject of a number of other research reports. StockNews.com upgraded Cellectar […]

Roth mkmCellectar biosciencesRenaissance technologiesCellectar biosciences incCitadel advisorsAcuta capital partnersCellectar biosciences company profileFree reportCapital partnersBridge advisorsStreet corpGet free reportCellectar biosciences daily

Short Interest in Cellectar Biosciences, Inc (NASDAQ:CLRB) Grows By 208 6%

Cellectar Biosciences, Inc. (NASDAQ:CLRB – Get Free Report) was the target of a significant growth in short interest during the month of January. As of January 15th, there was short interest totalling 1,670,000 shares, a growth of 208.6% from the December 31st total of 541,100 shares. Based on an average daily trading volume, of 1,130,000 […]

Cellectar biosciencesCellectar biosciences company profileWealth managementWorth venture partnersCitadel advisorsRenaissance technologiesCellectar biosciences incGet free reportStreet corpVenture partnersCellectar biosciences dailyNasdaq clrb

Financial Analysis: Cellectar Biosciences (NASDAQ:CLRB) vs Merrimack Pharmaceuticals (NASDAQ:MACK)

Financial Analysis: Cellectar Biosciences (NASDAQ:CLRB) vs Merrimack Pharmaceuticals (NASDAQ:MACK)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

New jerseyUnited statesFlorham parkUnited kingdomCellectar bioscienceCellectar biosciencesCellectar biosciences incMerrimack pharmaceuticals incMerrimack pharmaceuticalsGet free reportMerrimack pharmaceuticalGiven cellectar bioscienceOrano medCellectar biosciences daily